http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0670721-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f5b25fb16c28d1efd9dfd63c632e265
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b1967516b81bef84714907f8b9204d5
publicationDate 1995-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0670721-A1
titleOfInvention Drug for treatment and prophylaxis of bone and joint diseases
abstract The invention pertains to the use of benzopyrones and calcium dobesilate in the manufacture of a drug for treatment and prophylaxis of bone and joint diseases whose pathophysiology conforms to the principle of the compartment syndrome.
priorityDate 1992-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9852585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21530759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226514105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128712183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226758840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127404993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229694761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226875002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18782100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53642275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13713195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5293655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136289484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226758839

Total number of triples: 48.